← 返回

BLIMP1 负向调控 T 细胞中的 IL-2 信号传导

英文原题:BLIMP1 negatively regulates IL-2 signaling in T cells.

查看英文原题

BLIMP1 negatively regulates IL-2 signaling in T cells.

PubMed 2025/07/18(内容时间) Sci Adv Q1 · IF 13.9(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

白细胞介素-2(IL-2)通过精细调节效应T细胞与调节性T(T reg)细胞之间的平衡来维持免疫稳态。为鉴定IL-2信号通路的调控因子,我们在来源于成人T细胞白血病(ATL)患者的IL-2依赖性细胞中进行了全基因组CRISPR敲除筛选,发现靶向PRDM1的单向导RNA富集,PRDM1编码B淋巴细胞诱导成熟蛋白1(BLIMP1)。BLIMP1抑制T细胞产生IL-2;然而,其在IL-2信号传导中的作用尚不清楚。

在此,我们表明,过表达Prdm1下调IL-2信号传导,而Prdm1缺陷增强小鼠CD4+ T细胞和T reg细胞中的IL-2信号传导,在流感感染小鼠的T细胞以及过继性T细胞转移诱导的结肠炎中IL-2信号传导也增强。在人CD4+ T细胞和T reg细胞中敲除PRDM1同样增加IL-2信号传导。

此外,ATL患者的CD4+ T细胞表达较少的BLIMP1且IL-2信号传导增强,而在ATL细胞中过表达PRDM1则抑制IL-2信号传导。

因此,BLIMP1在正常和病理生理反应中抑制IL-2信号传导,提示调控BLIMP1可能具有治疗潜力。

展开英文摘要原文

Interleukin-2 (IL-2) regulates immune homeostasis by fine-tuning the balance between effector and regulatory T (T reg ) cells. To identify regulators of IL-2 signaling, we performed genome-wide CRISPR-knockout screening in IL-2-dependent cells derived from a patient with adult T cell leukemia (ATL) and found enrichment of single guide RNAs targeting PRDM1 , which encodes B lymphocyte-induced maturation protein 1 (BLIMP1). BLIMP1 inhibits IL-2 production by T cells; however, its role in IL-2 signaling remains unknown.

Here, we show that overexpressing Prdm1 down-regulated IL-2 signaling, whereas Prdm1 -deficiency enhanced IL-2 signaling in mouse CD4 + T cells and T reg cells with augmented IL-2 signaling in T cells from influenza-infected mice and during adoptive T cell transfer-induced colitis. Deleting PRDM1 in human CD4 + T cells and T reg cells also increased IL-2 signaling.

Furthermore, CD4 + T cells from patients with ATL expressed less BLIMP1 and had enhanced IL-2 signaling, whereas overexpressing PRDM1 in ATL cells suppressed IL-2 signaling.

Thus, BLIMP1 inhibits IL-2 signaling during normal and pathophysiological responses, suggesting that manipulating BLIMP1 could have therapeutic potential.

论文信息

作者
Roy S、Ren M、Li P、Cui K、Cao Y、Fisk B、Markowitz TE、Redekar N
单位
Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.United States
期刊
Science advances2025 Jul 18
原文标识
PubMed 40680114 · DOI 10.1126/sciadv.adx8105